Peng Zhan

78PUBLICATIONS

112CO-AUTHORS

Medical molecular engineering of nucleic acids and proteinsCheminformatics and quantitative structure-activity relationshipsBiologically active moleculesPharmacogenomicsCancer diagnosis

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (78)

Sort by Publication Date:

|Jul 13, 2026

Targeted Degradation of Capsid by Host-Hijacking PROTAC Overcomes Drug Resistance.

|Jul 07, 2026

Exploring Privileged Structure Repurposing: Target Similarity as a Catalyst for Cross-Species Drug Discovery.

|May 26, 2026

Pyridoimidazolyl Sulfonamide Compound 2: A Superior Dual-Acting Drug Candidate with Potent URAT1 Inhibition and Anti-Inflammatory Activity for Gout Management.

|May 15, 2026

Bridging the Gap between In Vitro and Intracellular: Systematic Analysis and Screening Optimization of Inconsistencies between Target Activity and Cellular-Level Activity.

|May 06, 2026

Discovery of a Novel Thienopyrimidine Derivative as a Potent Dual URAT1/GLUT9 Inhibitor with Enhanced Urate-Lowering Efficacy, Superior Pharmacokinetics, and Favorable Safety Profile for Gout and Hyperuricemia.

|Apr 17, 2026

A Novel Pyrrole Acylsulfonamide, Compound 42, as a Dual URAT1/GLUT9 Inhibitor: Potent Urate-Lowering Efficacy, Reduced Off-Target Effects, and Promising Druggability for Hyperuricemia.

Pageof 13

Frequent Collaborators

48 joint publications

Xinyong Liu

30 joint publications

Dongwei Kang

20 joint publications

Erik De Clercq

Mei Wang

Craig W Lindsley

Jianxin Pang

Xueping Hu

Jian Zhang

Zhao Wang

Boshi Huang

Frequent Collaborators

48 joint publications

Xinyong Liu

30 joint publications

Dongwei Kang

20 joint publications

Erik De Clercq

7 joint publications

Mei Wang